ATE336237T1 - Aryl-n-cyanoguanidine derivate und deren verwendung - Google Patents

Aryl-n-cyanoguanidine derivate und deren verwendung

Info

Publication number
ATE336237T1
ATE336237T1 AT02723339T AT02723339T ATE336237T1 AT E336237 T1 ATE336237 T1 AT E336237T1 AT 02723339 T AT02723339 T AT 02723339T AT 02723339 T AT02723339 T AT 02723339T AT E336237 T1 ATE336237 T1 AT E336237T1
Authority
AT
Austria
Prior art keywords
sub
compounds
methods
aryl
treating
Prior art date
Application number
AT02723339T
Other languages
English (en)
Inventor
Soumitra Ghosh
Tomas R Szabo
Original Assignee
Migenix Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Migenix Corp filed Critical Migenix Corp
Application granted granted Critical
Publication of ATE336237T1 publication Critical patent/ATE336237T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/28—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to cyano groups, e.g. cyanoguanidines, dicyandiamides
AT02723339T 2001-02-27 2002-02-27 Aryl-n-cyanoguanidine derivate und deren verwendung ATE336237T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27236801P 2001-02-27 2001-02-27

Publications (1)

Publication Number Publication Date
ATE336237T1 true ATE336237T1 (de) 2006-09-15

Family

ID=23039505

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02723339T ATE336237T1 (de) 2001-02-27 2002-02-27 Aryl-n-cyanoguanidine derivate und deren verwendung

Country Status (9)

Country Link
US (4) US6562821B2 (de)
EP (1) EP1377282B1 (de)
JP (1) JP2004525906A (de)
AT (1) ATE336237T1 (de)
AU (1) AU2002254124A1 (de)
CA (1) CA2475454A1 (de)
DE (1) DE60213958T2 (de)
ES (1) ES2271247T3 (de)
WO (1) WO2002068381A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6562821B2 (en) * 2001-02-27 2003-05-13 Mitokor Aryl-N-cyanoguanidines and methods related thereto
US7411000B2 (en) * 2001-03-15 2008-08-12 The Scripps Research Institute Process of inhibiting cell death in injured cartilage
WO2003050261A2 (en) * 2001-12-10 2003-06-19 Bristol-Myers Squibb Company (1-phenyl-2-heteroaryl)ethyl-guanidine compounds as inhibitors of mitochondrial f1f0 atp hydrolase
US7642092B2 (en) * 2003-03-03 2010-01-05 Technion Research & Development Foundation Ltd. Cultured cartilage/bone cells/tissue, method of generating same and uses thereof
CN111587117A (zh) * 2018-02-02 2020-08-25 白雁生物技术公司 用于预防或治疗类风湿性关节炎的、含线粒体的药物组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4265905A (en) 1975-09-30 1981-05-05 Merck & Co., Inc. Method of treating inflammation employing acyl cyanoguanidines
GB8400863D0 (en) 1984-01-13 1984-02-15 Smith Kline French Lab Chemical compounds
EA006079B1 (ru) 2000-03-31 2005-08-25 Пфайзер Продактс Инк. Новые пиперазиновые производные
US6562821B2 (en) * 2001-02-27 2003-05-13 Mitokor Aryl-N-cyanoguanidines and methods related thereto

Also Published As

Publication number Publication date
EP1377282B1 (de) 2006-08-16
AU2002254124A1 (en) 2002-09-12
US20030045556A1 (en) 2003-03-06
CA2475454A1 (en) 2002-09-06
DE60213958D1 (de) 2006-09-28
US6927218B2 (en) 2005-08-09
DE60213958T2 (de) 2007-08-30
US20080032981A1 (en) 2008-02-07
US6562821B2 (en) 2003-05-13
ES2271247T3 (es) 2007-04-16
EP1377282A2 (de) 2004-01-07
WO2002068381A2 (en) 2002-09-06
WO2002068381A3 (en) 2002-10-31
US20040067987A1 (en) 2004-04-08
US7230132B2 (en) 2007-06-12
JP2004525906A (ja) 2004-08-26
US20050182057A1 (en) 2005-08-18

Similar Documents

Publication Publication Date Title
EA200200509A1 (ru) Новые производные бензоимидазола, используемые в качестве антипролиферативного средства
EA200500174A1 (ru) Новые производные бензимидазола, полезные в качестве антипролиферативных агентов
ATE260263T1 (de) Heteroaromatische bizyklische verbindungen mit antikrebswirkung
EA200200716A1 (ru) Арилконденсированные азаполициклические соединения
EA200500018A1 (ru) Бензконденсированные гетероариламидные производные тиенопиридинов, применяемые в качестве терапевтических агентов, фармацевтические композиции, включающие их, и способы их применения
CY1109490T1 (el) Τρικυκλικοι τροποποιητες πυρηνικων υποδοχεων στεροειδων ορμονων
EA200500814A1 (ru) Производные пирролопиримидина
EA200100553A1 (ru) Замещенные бициклические производные, полезные в качестве противораковых агентов
BR0202547A (pt) Heterociclo-alquilsulfonil-pirazóis como agentes antiinflamatórios/analgésicos
DK1104758T3 (da) Acetylenderivativer som anti-inflammatoriske/analgesiske lægemidler
EA200000592A1 (ru) Азаполициклические соединения, конденсированные с арилом
BRPI0406883A (pt) Composto, composição farmacêutica, método de tratar um distúrbio, e, uso de um composto
EA200200106A1 (ru) Фармацевтическая композиция леводопа/карбидопа/энтакапон
ATE407928T1 (de) Amino-phtalazinon derivate, anwendung als kinase inhibitoren, herstellung und pharmazeutische zusammensetzung
CY1109355T1 (el) Πυριμιδινες υποκατεστημενες με αρυλιο και η χρηση αυτων
EA200401114A3 (ru) Замещённые гидроксиэтиламины
WO2003048164A3 (en) Adenosine a2a receptor antagonists
EA200200520A1 (ru) Производные гетероциклоалкилсульфонилпиразола в качестве противовоспалительных/анальгетических агентов
BR0316723A (pt) Derivados de anilinopirazol úteis para o tratamento de diabetes
DE69231298D1 (de) Substituierte Dibenzoxazepinverbindungen, pharmazeutische Zusammensetzungen und Anwendungsmethoden
ATE238981T1 (de) Antitumorwirkstoffe
EA200000996A1 (ru) Конденсированные с арилом азаполициклические соединения
BRPI0416882A (pt) composto, composição farmacêutica, método de tratar um distúrbio, e, uso de um composto
BR0315462A (pt) Composto, composição farmacêutica, uso de um composto, método para o tratamento de um sujeito que sofre de uma condição patológica ou de doença susceptìvel de alìvio por antagonismo de receptores de ltd4 e produto de combinação
ATE336237T1 (de) Aryl-n-cyanoguanidine derivate und deren verwendung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties